ArticleVeterinary research communications2025
Residue depletion and temperature- and dose-dependent withdrawal period of Oxolinic acid in Japanese eel Anguilla Japonica following bath administration under laboratory and field conditions.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Oxolinic acid (OA) is a quinolone class antimicrobial agent widely used in aquaculture, yet its off-label application via bath administration in Japanese eel (Anguilla japonica) has raised concerns regarding tissue residue persistence and appropriate withdrawal periods (WTs). This study aimed to investigate the residue depletion kinetics and calculate the WTs of OA in A. japonica following 12 h bath treatment under different water temperatures (20 °C and 28 °C) and exposure concentrations (10 and 20 mg/L). Laboratory trials were conducted under controlled conditions using recirculating systems, and additional field validation was performed at a commercial aquaculture farm. Residue concentrations in muscle plus skin were quantified using validated LC-MS/MS, and depletion data were modeled using first-order exponential regression. The calculated depletion half-lives ranged from 5.46 to 18.24 days, showing temperature- and dose-dependent variation. Corresponding WTs, derived from 95/95 statistical tolerance limits, were 78.8 and 115.7 days at 20 °C, and 27.4 and 55.9 days at 28 °C for the 10 and 20 mg/L groups, respectively. The WT estimated under farm conditions (47.3 days) closely matched the laboratory-derived value, demonstrating that laboratory-based models can reasonably predict field outcomes under similar conditions. All calculated WTs markedly exceeded the currently approved 25 days WT for oral administration of OA in eels, suggesting that extended WTs may be warranted following immersion exposure. These findings support the establishment of temperature- and concentration-dependent WTs under the conditions studied, which may help improve regulatory compliance and consumer protection in eel aquaculture.
Indexed as
Identifiers
41148482What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.